Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sagittarius Life Science Corp. (3205:TWSE), powered by AI.
Sagittarius Life Science Corp. is currently trading at $52.80. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sagittarius Life Science Corp. on Alpha Lenz.
View Sagittarius Life Science Corp.'s valuation metrics on Alpha Lenz.
“Sagittarius Life Science Corp.'s ROE is -6.8%. Explore profitability and growth together.”
Ask for details →Sagittarius Life Science Corp. is a biotechnology and health-focused company specializing in the research, development, and production of both Chinese and Western medicines as well as a diverse array of health products. Founded in 1998 and headquartered in Taipei, the company’s core operations span nutritional supplements, organic and natural foods, probiotic fermentation products, and beauty care ingredients. Additionally, Sagittarius Life Science Corp. provides health-related daily necessities, pet food, and functional beverages, catering to varying consumer health and wellness needs across Taiwan, broader Asia, and select international markets. The company’s activities extend into the innovative development of plant-derived pharmaceuticals and traditional herbal medicines, reflecting a blend of modern biotechnological approaches with established medicinal practices. Through its integrated model that covers R&D, manufacturing, and technical consulting for pharmaceutical products, Sagittarius Life Science Corp. maintains a significant presence in the healthcare and specialty food sectors, with a focus on promoting well-being and supporting advancements in preventive and supplementary health care.
“Sagittarius Life Science Corp.'s ROE is -6.8%. Explore profitability and growth together.”
Ask for details →Sagittarius Life Science Corp. (ticker: 3205) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 52.8 with a P/E ratio of -x and P/B of -x.
ROE is -6.83% and operating margin is -16.91%. Annual revenue is $346M.